Found "Public health policy": 1,139 results
Design and development of system and tools for prioritizing local health innovations in the early stages to increase the chances of local health innovation being included in the benefit package in the public health insurance schemes in Thailand
The development of medical innovation is one of Thailand’s key strategic priorities, as outlined in the 13th National Economic and Social Development Plan (2023–2027), with Milestone 4 positioning Thailand as a hub for high-value medical and healthcare services. However, Thailand’s research and development in medical technologies and health i
Comprehensive assessment of co-benefits and maladaptation of solarisation in Thailand
Thailand’s increasing demand for coal and fossil fuel-based energy has substantial climate, environmental, and public health consequences. In response, the Ministry of Energy has ambitious plans to increase the share of renewable energy to over 50% by 2037. A high priority intervention included in this plan is photovoltaic systems or ‘solarisat
HTA Capacity Development across Asia
There was an overriding theme that HITAP’s activities focused on during the Prince Mahidol Award Conference (PMAC) 2015 – priority setting, which is also the theme for next year’s PMAC. As a new member of the HITAP team, I was involved in different activities during the Conference, particularly help
Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.
Research Proposal: Economic evaluation of an integrated care on delaying chronic kidney disease progression in rural communities of Thailand
In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht f
The Lancet Commission for Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
Epidemiological modelling is an important tool to help public health planners understand potential disease outcomes in the population. The recent visibility of models and their perceived influence in the decision-making processes surrounding the response to the COVID-19 pandemic has led to a great d
Navigating the Landscape of Digital Health: Australia
Executive Summary
Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De
E2U from HITAP Launches ‘CAST Solar’ to Fast-Track Thailand’s 2050 Net Zero Goal, Linking Clean Energy Directly to Public Health and Social Equity.
BANGKOK, April 3, 2026 – At the Best Western Chatuchak Hotel, the Environmental Economics Unit (E2U) of the Health Intervention and Technology Assessment Program Foundation (HITAP), alongside national energy and environmental partners, hosted a milestone seminar: “Comprehensive Assessment of Co-bene
Indonesia’s Commitment to Evidence-Informed Decision Making
Indonesia launched its universal healthcare program in January 2014, a process that had been initiated in 2004. The scheme, Jaminan Kesehatan Nasional or JKN, is administered by a public agency called Badan Penyelenggara Jamina Sosial or BPJS Health and is expected to cover all citizens by 2019. Wi
Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop: From participant’s perspective
This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e
10 / Page